Key Takeaways
- Veragrow has secured USD 5.2 million (equivalent to €4.5 million) to expand commercial operations, increase production capacity, and accelerate R&D.
- The investment round includes participation from Odyssée Venture, Normandie Participations, CEN Innovation (Caisse d’Épargne Normandie Innovation), and Groupe All Sun.
- Funding will support national and international expansion, including six new formulations planned for 2026.
- The company's lombricompost-derived biostimulants have shown strong performance across 930+ field trials.
- The company aims to become a leading global biostimulant manufacturer by 2030.
Veragrow Secures USD 5.2 Million to Scale Its Agricultural Biostimulants and Support Sustainable Farming
Veragrow, a French agribiotech company specializing in lombricompost-derived biostimulants, has raised USD 5.2 million in its latest funding round to accelerate commercial expansion and strengthen its position within the growing biostimulants market. The round was backed by Odyssée Venture, Normandie Participations, CEN Innovation, and Groupe All Sun.
The capital will help Veragrow reinforce its sales network, extend distribution domestically and internationally, expand production capacity at its Val-de-Reuil facility, and accelerate R&D activities to address increasing market demand.
Veragrow’s Technology Demonstrates Strong Agronomic Performance
Founded in 2019, Veragrow uses a proprietary extraction and stabilization process that isolates active compounds produced by more than 25 million earthworms converting agricultural co-products into high-value lombricompost.
The resulting biostimulant formulations—combining lombricompost extracts with plant-based ingredients—deliver improvements in soil structure, crop growth, stress tolerance, and yield quality.
Over 930 field trials across major crops—including wheat, maize, potatoes, sugar beet, OSR, flax, vineyards, and vegetables—have confirmed Veragrow's agronomic performance. By 2025, the company had secured distribution through 30+ partners in France and initiated field trials in 20+ countries, spanning Denmark, Morocco, Brazil, and Senegal.
Integrated Scientific and Industrial Model Underpins Veragrow’s Growth Strategy
Veragrow operates a fully integrated model covering R&D, production, and commercialization. The company collaborates with leading scientific institutions such as INRAE, CNRS, UniLaSalle, and GlycoMev, ensuring continued development grounded in rigorous agronomic research.
Support from France 2030, BPI France, FEDER, FEADER, and the Normandie Region has reinforced Veragrow’s innovation pipeline and industrial capacity.
Veragrow Sets Ambitious Roadmap Toward 2030 Leadership
With the new USD 5.2 million financing, Veragrow plans to expand its product line, increase production output, and strengthen its international presence. Six new formulations are expected to launch in 2026 to support a broader range of crops, climatic conditions, and soil needs.
“Our ambition is clear: to make Veragrow an essential global player in bio-based biostimulants,” said Alexandre Bocage, co-founder and president of Veragrow. He emphasized the role biostimulants will play in both economic resilience and environmental sustainability for farmers worldwide.
